<DOC>
	<DOCNO>NCT02610504</DOCNO>
	<brief_summary>Open label , prospective , single cohort study Durolane 3ml intra-articular injection shoulder pain mild moderate patient</brief_summary>
	<brief_title>Prospective Single Center Open Label Study Shoulder OA Pain</brief_title>
	<detailed_description>Subjects 19-85 year old receive single intra-articular ( IA ) injection DUROLANEÂ® 3mL give relief pain treatment symptomatic osteoarthritis ( OA ) shoulder follow 26-week time period .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Diagnosis glenohumeral osteoarthritis SPOM score great equal 50 study shoulder Willing discontinue oral topical analgesia rescue acetaminophen abstinence IA perarticular injection shoulder course trial patient chronic shoulder pain last 6 month without clinically significant improvement pain past one month pain least 50 % day previous month patient fail conventional therapy NSAIDs steroid injection patient retain active range motion least 30 % direction rule frozen shoulder cooperative able communicate effectively agree participate study trial significant pain joint require chronic analgesic therapy presence one condition besides OA could confound pain functional assessment clinically apparent tense effusion , malalignment instability study shoulder shoulder xrays acute fracture , sever loss bone density , avascular necrosis severe deformity inability abstain analgesic use rescue acetaminophen IA injection steroid study shoulder within 3 month joint within prior month IA injection hyaluronic acid study shoulder within 9 month baseline allergic reaction HA medical condition opinion investigator make patient unsuitable inclusion may compromise pain assessment shoulder uncontrolled hypothyroidism pregnant breastfeed woman plan surgical procedure history presence septic arthritis study joint active skin disease infection area injection site treatment glucosamine/chondroitin initiate unstable within 3 month baseline change physical therapy study shoulder within 1 month baseline</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>degenerative arthritis</keyword>
</DOC>